Position in CHRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$107,280
-$659,579 QoQ
Shares Held
76,629
-83.1% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 145 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SEI INVESTMENTS CO holds $1,244,853,716 across 210 Biotechnology names. CHRS ranks #187 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
255,073 | $236,649,076 | |
| 2 | INSM |
INSMED Inc
|
1,015,870 | $108,312,059 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
129,981 | $64,565,461 | |
| 4 | EXEL |
Exelixis, Inc.
|
1,166,715 | $63,480,962 | |
| 5 | ASND |
Ascendis Pharma A/S
|
237,869 | $63,444,419 | |
| 6 | INCY |
Incyte Corp
|
498,013 | $56,454,752 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
551,116 | $43,135,848 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
60,441 | $37,687,380 |
All Filings in CHRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $107,280 | 76,629 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $766,859 | 453,763 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $108,813 | 76,629 | Shares | Sole | 2026-02-13 | |
| 2024-09-30 | $356,124 | 342,427 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $614,828 | 355,392 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $853,177 | 356,978 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,216,855 | 365,422 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,138,297 | 839,117 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $3,636,609 | 851,665 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,037,789 | 736,519 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $5,365,942 | 677,518 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $6,371,045 | 662,960 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,793,509 | 662,087 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $8,082,873 | 626,094 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $8,585,394 | 537,932 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,528,321 | 344,015 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,964,790 | 358,987 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $5,253,010 | 359,549 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $5,459,214 | 314,109 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $3,774,005 | 205,780 | Shares | Defined | 2020-12-04 | |
| 2020-06-30 | $1,951,240 | 109,252 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $307,238 | 18,942 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||